Condition or Therapy:

Pamidronate (medication); stem cell transplant, bone marrow transplant, bone loss, bone density (conditions)

Category:

Transplant; Hematology-Oncology 

What is the goal of this study?

Weak bones are common in kids and young adults who get transplants and can lead to bone problems later in life, such as osteoporosis and fractures. We want to find out if a medication called Pamidronate, when given in addition to calcium and vitamin D, will help prevent bone loss better than calcium and vitamin D alone.

Who can join the study?

You might be eligible for the study if:

  • You are between 1 and 20 years old; and
  • You are scheduled to receive a stem cell transplant (also called bone marrow transplant)

What will happen if my child takes part in this study?

Read about the study on clinicaltrials.gov.

Who can I contact for more information?

You can call the study team at 206-667-4222 or send us an email.


Study Location(s):

Seattle Children's Hospital main campus and Seattle Cancer Care Alliance

Principal Investigator:

Dr. Scott Baker

Study posted: June 27, 2019